{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreigueysecw5zypd6ldpoethwudpsz2dvl56n63i5dvm34i2pxqq6m4",
    "uri": "at://did:plc:5ka4qkui7nvjms7idhte2m4o/app.bsky.feed.post/3mkpirv3n2u22"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreieihnvsar7gebuadbkt6wb6zwwd762nuc4lqilfpn6yilramgm43y"
    },
    "mimeType": "image/jpeg",
    "size": 55967
  },
  "path": "/2026/04/30/akeso-summit-therapeutics-drug-ivonescimab-results-announced-asco/?utm_campaign=rss",
  "publishedAt": "2026-04-30T10:30:00.000Z",
  "site": "https://www.statnews.com",
  "tags": [
    "Adam's Biotech Scorecard",
    "Adam's Take",
    "Biotech",
    "ASCO",
    "biotechnology",
    "STAT+"
  ],
  "textContent": "Mystery cloaks an ASCO plenary lung cancer survival result.",
  "title": "STAT+: What does Akeso’s primo plenary spot say about its survival data?",
  "updatedAt": "2026-04-30T00:11:54.000Z"
}